VAN ZUILEN WILFRED 4

What Happened

• Wilfred Van Zuilen, Group President, EMEA at Zimmer Biomet (ZBH), had RSUs convert/vest on 2026-03-06. A total of 7,004 RSUs converted into 7,004 shares (two conversions: 4,843 and 2,161 shares). To satisfy tax withholding, the company withheld 1,260 and 562 shares (total 1,822 shares) at $92.54 per share, generating withholding proceeds of $116,600 and $52,007 respectively (total ≈ $168,607). Net shares delivered to him after withholding were 5,182 shares.
• The filing shows both the conversion (transaction code M) and the share withholding for taxes (transaction code F). Two entries reporting disposal of the derivative reflect the settlement/conversion of the RSUs into common stock.

Key Details

• Transaction date: 2026-03-06; Form 4 filed 2026-03-10 (appears to be filed within the standard two-business-day window).
• Conversions (M): 4,843 shares and 2,161 shares acquired at $0.00 (RSU settlement).
• Withholding (F): 1,260 shares and 562 shares withheld at $92.54/share (total withheld value ≈ $168,607).
• Net shares received: 7,004 converted − 1,822 withheld = 5,182 shares.
• Footnotes: F1 indicates shares were withheld by the company to satisfy tax withholding on RSU vesting; F2 notes each RSU equals one share of common stock.
• Shares owned after the transaction are not disclosed in the provided excerpt.

Context

• This was a vesting/settlement of RSUs with a net share settlement (shares withheld to cover taxes)—a routine, non-open-market transaction that generally reflects compensation vesting rather than a buy/sell signal.
• For retail investors, such withholding is standard practice (cashless/net settlement) and should not be interpreted as an insider selling shares on the market.